pI: 5.3477 |
Length (AA): 1233 |
MW (Da): 146148 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 13 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
6 | 331 | 3v0a (B) | 788 | 1190 | 28.00 | 0.00033 | 0.49 | 0.194196 | 0.99 |
674 | 926 | 4fbk (B) | 1092 | 1354 | 36.00 | 0 | 1 | 0.525191 | 0.63 |
684 | 920 | 4fcx (B) | 99 | 349 | 42.00 | 0 | 1 | 0.448014 | 1.14 |
697 | 932 | 3t1i (A) | 120 | 360 | 41.00 | 0 | 1 | 0.569203 | 0.62 |
1027 | 1212 | 4uos (A) | 1 | 184 | 9.00 | 0.0006 | 0 | 0.344152 | -1.47 |
6 | 315 | 3v0a (B) | 788 | 1182 | 29.00 | 0.0031 | 0.54 | 0.140025 | 1.08 |
16 | 202 | 3uau (A) | 81 | 259 | 30.00 | 0.14 | 0.08 | 0.194957 | 0.76 |
658 | 912 | 4fbk (B) | 1092 | 1356 | 36.00 | 0 | 1 | 0.540732 | 0.52 |
668 | 904 | 4fcx (B) | 99 | 349 | 42.00 | 0 | 1 | 0.450041 | 1.14 |
675 | 926 | 3t1i (A) | 96 | 370 | 38.00 | 0 | 1 | 0.532267 | 0.58 |
1030 | 1215 | 4uos (A) | 1 | 183 | 11.00 | 0.0077 | 0.03 | 0.290035 | -1.14 |
23 | 176 | 4uos (A) | 20 | 176 | 16.00 | 0.014 | 0.03 | 0.38897 | -1.04 |
293 | 376 | 4tql (A) | 83 | 173 | 33.00 | 0.63 | 0.05 | 0.273874 | -0.1 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Sporozoite. | Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Oocyst. | Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 32 hs. | Otto TD |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, Ring, Female Gametocyte, Male Gametocyte. | Otto TD Zanghi G Lasonder E |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Ortholog group members (OG5_127969)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G54260 | double-strand break repair protein MRE11 |
Babesia bovis | BBOV_III007250 | DNA repair protein (mre11) family protein |
Brugia malayi | Bm1_21560 | double-strand break repair protein mre-11 |
Candida albicans | CaO19_6915 | hypothetical protein |
Candida albicans | CaO19.6915 | meiotic recombination complex |
Caenorhabditis elegans | CELE_ZC302.1 | Protein MRE-11 |
Cryptosporidium hominis | Chro.10164 | DNA repair and meiosis protein Mre11 (emb |
Cryptosporidium parvum | cgd1_1420 | DNA repair and meiosis protein Mre11 (emb |
Dictyostelium discoideum | DDB_G0293546 | 3'-5' exonuclease |
Drosophila melanogaster | Dmel_CG16928 | meiotic recombination 11 |
Echinococcus granulosus | EgrG_000145400 | double strand break repair protein MRE11A |
Entamoeba histolytica | EHI_125910 | double-strand break repair protein MRE11, putative |
Echinococcus multilocularis | EmuJ_000145400 | double strand break repair protein MRE11A |
Echinococcus multilocularis | EmuJ_000139050 | double strand break repair protein MRE11A |
Giardia lamblia | GL50803_14493 | Mre11, putative |
Homo sapiens | ENSG00000020922 | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) |
Leishmania braziliensis | LbrM.27.2030 | endo/exonuclease Mre11, putative |
Leishmania donovani | LdBPK_271790.1 | endo/exonuclease Mre11, putative |
Leishmania infantum | LinJ.27.1790 | endo/exonuclease Mre11, putative |
Leishmania major | LmjF.27.1890 | endo/exonuclease Mre11, putative |
Leishmania mexicana | LmxM.27.1890 | endo/exonuclease Mre11, putative |
Loa Loa (eye worm) | LOAG_00022 | hypothetical protein |
Mus musculus | ENSMUSG00000031928 | meiotic recombination 11 homolog A (S. cerevisiae) |
Neospora caninum | NCLIV_067970 | double-strand break repair protein, putative |
Oryza sativa | 4337137 | Os04g0635900 |
Plasmodium berghei | PBANKA_0205600 | double-strand break repair protein MRE11, putative |
Plasmodium falciparum | PF3D7_0107800 | double-strand break repair protein MRE11 |
Plasmodium knowlesi | PKNH_0205800 | double-strand break repair protein MRE11, putative |
Plasmodium vivax | PVX_081385 | double-strand break repair protein MRE11, putative |
Plasmodium yoelii | PY06177 | rad32-related |
Saccharomyces cerevisiae | YMR224C | Mre11p |
Schistosoma japonicum | Sjp_0069970 | Double-strand break repair protein MRE11A, putative |
Schistosoma mansoni | Smp_068110 | meiotic recombination repair protein 11 (mre11) |
Schmidtea mediterranea | mk4.014816.00 | Mre11-like protein |
Schmidtea mediterranea | mk4.006709.01 | Double-strand break repair protein MRE11A |
Trypanosoma brucei gambiense | Tbg.972.2.2460 | endo/exonuclease Mre11, putative |
Trypanosoma brucei | Tb927.2.4390 | endo/exonuclease Mre11 |
Trypanosoma congolense | TcIL3000_2_790 | endo/exonuclease Mre11, putative |
Trypanosoma cruzi | TcCLB.509099.70 | endo/exonuclease Mre11, putative |
Trypanosoma cruzi | TcCLB.509319.60 | endo/exonuclease Mre11, putative |
Toxoplasma gondii | TGME49_278060 | Mre11 DNA-binding domain-containing protein |
Theileria parva | TP04_0621 | DNA repair exonuclease, putative |
Trichomonas vaginalis | TVAG_098295 | nuclease Mre11 |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.2.4390 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.2.4390 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.2.4390 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.2.4390 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_ZC302.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
TGME49_278060 | Toxoplasma gondii | Essentiality uncertain | sidik |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | Compounds | References |